This inhibitor suppresses H3K27 trimethylation levels in cells and selectively inhibits both B cell lymphoma cell lines and growth of mixed lineage leukemia (MLL)-rearranged leukemia cells [33]. Here, KMT2A is linked to B-cell non-Hodgkin lymphoma.